Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obstructive Lung Diseases

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    June 2021
  1. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed     Abstract available


    May 2021
  2. KIM LHY, Saleh C, Whalen-Browne A, O'Byrne PM, et al
    Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.
    JAMA. 2021 May 19. pii: 2780374. doi: 10.1001/jama.2021.7872.
    PubMed     Abstract available


  3. XIONG W
    Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD.
    JAMA. 2021;325:1901-1902.
    PubMed    


  4. FRANCIOSI AN, McCarthy C
    Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD.
    JAMA. 2021;325:1902-1903.
    PubMed    


  5. COUTURAUD F, Sanchez O, Bertoletti L
    Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD-Reply.
    JAMA. 2021;325:1903.
    PubMed    


    January 2021
  6. COUTURAUD F, Bertoletti L, Pastre J, Roy PM, et al
    Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms.
    JAMA. 2021;325:59-68.
    PubMed     Abstract available


    December 2020
  7. CLOUTIER MM, Dixon AE, Krishnan JA, Lemanske RF Jr, et al
    Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
    JAMA. 2020 Dec 3. pii: 2773482. doi: 10.1001/jama.2020.21974.
    PubMed     Abstract available


  8. LOVINSKY-DESIR S, O'Connor GT
    Evolving Strategies for Long-term Asthma Management.
    JAMA. 2020 Dec 3. pii: 2773481. doi: 10.1001/jama.2020.16895.
    PubMed    


    November 2020
  9. SCHUH S, Sweeney J, Rumantir M, Coates AL, et al
    Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial.
    JAMA. 2020;324:2038-2047.
    PubMed     Abstract available


    October 2020
  10. SMITH BM, Hoffman EA, Barr RG
    Dysanapsis and COPD-Reply.
    JAMA. 2020;324:1572.
    PubMed    


  11. UZOIGWE CE
    Dysanapsis and COPD.
    JAMA. 2020;324:1571.
    PubMed    


  12. QUINN KL, Shurrab M, Gitau K, Kavalieratos D, et al
    Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness: A Systematic Review and Meta-analysis.
    JAMA. 2020;324:1439-1450.
    PubMed     Abstract available


  13. BETTENCOURT AP, Schondelmeyer AC, Bonafide CP
    Continuous Pulse Oximetry Monitoring in Bronchiolitis Patients Not Receiving Oxygen-Reply.
    JAMA. 2020;324:1350-1351.
    PubMed    


  14. KEIM-MALPASS J, Sullivan BA, Moorman JR
    Continuous Pulse Oximetry Monitoring in Bronchiolitis Patients Not Receiving Oxygen.
    JAMA. 2020;324:1349-1350.
    PubMed    


    August 2020
  15. FORNO E, Bacharier LB, Phipatanakul W, Guilbert TW, et al
    Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
    JAMA. 2020;324:752-760.
    PubMed     Abstract available


    July 2020
  16. ADIBI A, Sadatsafavi M, Ioannidis JPA
    Validation and Utility Testing of Clinical Prediction Models: Time to Change the Approach.
    JAMA. 2020;324:235-236.
    PubMed    


    June 2020
  17. WILSON ME, Murad MH, Wang Z
    Home Noninvasive Positive Pressure Ventilation for Chronic Obstructive Pulmonary Disease-Reply.
    JAMA. 2020;323:2432-2433.
    PubMed    


  18. OWENS RL, Oczkowski S, Rochwerg B
    Home Noninvasive Positive Pressure Ventilation for Chronic Obstructive Pulmonary Disease.
    JAMA. 2020;323:2432.
    PubMed    


  19. BUNYAVANICH S, Do A, Vicencio A
    Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
    JAMA. 2020;323:2427-2429.
    PubMed    


  20. SMITH BM, Kirby M, Hoffman EA, Kronmal RA, et al
    Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
    JAMA. 2020;323:2268-2280.
    PubMed     Abstract available


    May 2020
  21. LINDENAUER PK, Stefan MS, Pekow PS, Mazor KM, et al
    Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries.
    JAMA. 2020;323:1813-1823.
    PubMed     Abstract available


  22. ROCHESTER CL, Holland AE
    Pulmonary Rehabilitation and Improved Survival for Patients With COPD.
    JAMA. 2020;323:1783-1785.
    PubMed    


    April 2020
  23. CHESTON CC, Vinci RJ
    Overuse of Continuous Pulse Oximetry for Bronchiolitis: The Need for Deimplementation Science.
    JAMA. 2020;323:1449-1450.
    PubMed    


  24. BONAFIDE CP, Xiao R, Brady PW, Landrigan CP, et al
    Prevalence of Continuous Pulse Oximetry Monitoring in Hospitalized Children With Bronchiolitis Not Requiring Supplemental Oxygen.
    JAMA. 2020;323:1467-1477.
    PubMed     Abstract available


  25. TSAI C
    Personal Risk and Societal Obligation Amidst COVID-19.
    JAMA. 2020 Apr 3. pii: 2764319. doi: 10.1001/jama.2020.5450.
    PubMed    


    February 2020
  26. ZAIDAN MF, Ameredes BT, Calhoun WJ
    Management of Acute Asthma in Adults in 2020.
    JAMA. 2020;323:563-564.
    PubMed    


  27. TRIPPLE JW, Ameredes BT, Calhoun WJ
    Outpatient Management of Chronic Asthma in 2020.
    JAMA. 2020;323:561-562.
    PubMed    


  28. ZORATTI EM, O'Connor GT
    New Therapeutic Strategies for Asthma.
    JAMA. 2020;323:517-518.
    PubMed    


  29. COLEMAN JM 3RD, Gates KL, Kalhan R
    Home Noninvasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease and Chronic Respiratory Failure.
    JAMA. 2020;323:421-422.
    PubMed    


  30. WILSON ME, Dobler CC, Morrow AS, Beuschel B, et al
    Association of Home Noninvasive Positive Pressure Ventilation With Clinical Outcomes in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
    JAMA. 2020;323:455-465.
    PubMed     Abstract available


    October 2019
  31. BHATT SP, Schwartz JE, Oelsner EC
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease-Reply.
    JAMA. 2019;322:1611-1612.
    PubMed    


  32. HAN X, Zhang Y
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1611.
    PubMed    


  33. MILLER MR, Stanojevic S
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1609-1610.
    PubMed    


  34. VAZ FRAGOSO CA
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1610-1611.
    PubMed    


  35. BAUCHNER H, Golub RM
    Ensuring an Accurate Scientific Record-Retraction and Republication.
    JAMA. 2019;322:1380.
    PubMed    


  36. RINNE ST, Lindenauer PK, Au DH
    Unexpected Harm From an Intensive COPD Intervention.
    JAMA. 2019;322:1357-1359.
    PubMed    


  37. ABOUMATAR H, Naqibuddin M, Chung S, Chaudhry H, et al
    Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
    JAMA. 2019;322:1371-1380.
    PubMed     Abstract available


    August 2019
  38. WANG M, Aaron CP, Madrigano J, Hoffman EA, et al
    Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function.
    JAMA. 2019;322:546-556.
    PubMed     Abstract available


    July 2019
  39. RILEY L, Brantly M, Ataya A
    A Woman With Dyspnea and Bronchiectasis.
    JAMA. 2019 Jul 5. pii: 2737853. doi: 10.1001/jama.2019.8606.
    PubMed    


    June 2019
  40. VESTBO J, Lange P
    Accuracy of Airflow Obstruction Thresholds for Predicting COPD-Related Hospitalization and Mortality: Can Simple Diagnostic Thresholds Be Used for a Complex Disease?
    JAMA. 2019;321:2412-2413.
    PubMed    


  41. BHATT SP, Balte PP, Schwartz JE, Cassano PA, et al
    Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
    JAMA. 2019;321:2438-2447.
    PubMed     Abstract available


    May 2019
  42. GARCIA E, Berhane KT, Islam T, McConnell R, et al
    Association of Changes in Air Quality With Incident Asthma in Children in California, 1993-2014.
    JAMA. 2019;321:1906-1915.
    PubMed     Abstract available


  43. THURSTON GD, Rice MB
    Air Pollution Exposure and Asthma Incidence in Children: Demonstrating the Value of Air Quality Standards.
    JAMA. 2019;321:1875-1877.
    PubMed    


  44. ABOUMATAR H, Wise RA
    Self-medication as Part of Self-management Plans for Patients With COPD-Reply.
    JAMA. 2019;321:1937.
    PubMed    


  45. STEURER-STEY C
    Self-medication as Part of Self-management Plans for Patients With COPD.
    JAMA. 2019;321:1937.
    PubMed    


  46. WISE RA, Chapman KR, Scirica BM, Bhatt DL, et al
    Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
    JAMA. 2019;321:1693-1701.
    PubMed     Abstract available


    March 2019

  47. Dupilumab (Dupixent) for Asthma.
    JAMA. 2019;321:1000-1001.
    PubMed    


  48. BRUSTAD N, Eliasen AU, Stokholm J, Bonnelykke K, et al
    High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years.
    JAMA. 2019;321:1003-1005.
    PubMed    


    February 2019
  49. RILEY CM, Sciurba FC
    Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
    JAMA. 2019;321:786-797.
    PubMed     Abstract available


    December 2018
  50. RINNE ST, Lindenauer PK, Au DH
    Intensive Intervention to Improve Outcomes for Patients With COPD.
    JAMA. 2018;320:2322-2324.
    PubMed    


  51. ABOUMATAR H, Naqibuddin M, Chung S, Chaudhry H, et al
    Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
    JAMA. 2018;320:2335-2343.
    PubMed     Abstract available


    October 2018
  52. CRINER GJ, Celli BR
    Failure of Low-Dose Theophylline to Prevent Exacerbations in Patients With COPD.
    JAMA. 2018;320:1541-1542.
    PubMed    


  53. DEVEREUX G, Cotton S, Fielding S, McMeekin N, et al
    Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    JAMA. 2018;320:1548-1559.
    PubMed     Abstract available


  54. BURSTEIN B, Plint AC, Papenburg J
    Use of Radiography in Patients Diagnosed as Having Acute Bronchiolitis in US Emergency Departments, 2007-2015.
    JAMA. 2018;320:1598-1600.
    PubMed    


    September 2018
  55. SOBIERAJ DM, Baker WL
    SMART in the Management of Patients With Persistent Asthma-Reply.
    JAMA. 2018;320:934.
    PubMed    


  56. XIA Y, Xia L, Shen H
    SMART in the Management of Patients With Persistent Asthma.
    JAMA. 2018;320:933-934.
    PubMed    


    August 2018
  57. VOELKER R
    Relieving Severe Emphysema Symptoms.
    JAMA. 2018;320:431.
    PubMed    


    May 2018
  58. HALES CM, Kit BK, Gu Q, Ogden CL, et al
    Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.
    JAMA. 2018;319:2009-2020.
    PubMed     Abstract available


  59. HURLEY K, O'Connor GT
    Serum alpha1-Antitrypsin Concentration in the Diagnosis of alpha1-Antitrypsin Deficiency.
    JAMA. 2018;319:2034-2035.
    PubMed    


    April 2018
  60. SOBIERAJ DM, Baker WL
    Medications for Asthma.
    JAMA. 2018;319:1520.
    PubMed    



  61. Benralizumab (Fasenra) for Severe Eosinophilic Asthma.
    JAMA. 2018;319:1501-1502.
    PubMed    


    March 2018
  62. KRISHNAN JA, Au DH
    Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.
    JAMA. 2018 Mar 19. pii: 2675735. doi: 10.1001/jama.2018.2029.
    PubMed    


  63. SOBIERAJ DM, Weeda ER, Nguyen E, Coleman CI, et al
    Association of Inhaled Corticosteroids and Long-Acting beta-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    JAMA. 2018 Mar 19. pii: 2675737. doi: 10.1001/jama.2018.2769.
    PubMed     Abstract available


  64. SOBIERAJ DM, Baker WL, Nguyen E, Weeda ER, et al
    Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.
    JAMA. 2018 Mar 19. pii: 2675736. doi: 10.1001/jama.2018.2757.
    PubMed     Abstract available


    November 2017
  65. PRESS VG, Cifu AS, White SR
    Screening for Chronic Obstructive Pulmonary Disease.
    JAMA. 2017;318:1702-1703.
    PubMed    


  66. WILKE RA, Freeman JW
    Potential Health Implications Related to Fracking.
    JAMA. 2017;318:1645-1646.
    PubMed    


    October 2017
  67. HORITA N, Nagashima A, Kaneko T
    Long-Acting beta-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD.
    JAMA. 2017;318:1274-1275.
    PubMed     Abstract available


    September 2017
  68. DWYER-LINDGREN L, Bertozzi-Villa A, Stubbs RW, Morozoff C, et al
    Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014.
    JAMA. 2017;318:1136-1149.
    PubMed     Abstract available


    August 2017
  69. CABITZA F, Rasoini R, Gensini GF
    Unintended Consequences of Machine Learning in Medicine.
    JAMA. 2017;318:517-518.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: